Pyxis Oncology, Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-8.8% -$2M
$-23M
Free Cash Flow
$0
Investing Cash Flow↓-39.0% -$10M
$16M
Financing Cash Flow↑+1238.0% +$619K
$669K
Capex
$0
Stock-Based Comp↓-24.9% -$691K
$2M
D&A↑+426.7% +$2M
$3M
SBC Allocated Expense↓-24.9% -$691K
$2M